CPC technology class · D21
D21B - Fibrous Raw Materials Or Their Mechanical Treatment
Fibrous raw materials or their mechanical treatment. 452 US utility patents granted 2015–2025, with the leading assignees and year-by-year grant trajectory.
- 452
- US patents granted
- #4/7
- in D21
- 5.5%
- D21 class share
- +11%
- 5-yr velocity
The verdict
According to USPTO PatentsView, Fibrous Raw Materials Or Their Mechanical Treatment ranks #550 of 670 CPC technology areas - 452 US patents granted since 2015, with recorded grant volume up 11% over five years.
- #550
- of 670 CPC technology areas
- 452
- US patents granted, 2015–2025
- Seiko Epson
- leading assignee (111)
- +11%
- grant velocity, last 5 yrs
How D21B's grant cadence moved
Between 2020–2024, D21B recorded 217 grants versus 195 in 2015–2019 (+11% equal-window velocity). Across complete years, output peaked in 2021 at 57 grants and bottomed in 2018 at 32 (+78% peak-over-trough). Lead assignee Xyleco, Inc. holds 6.4% of the class ; the top three share 13.9%.
Leaderboard read
D21B concentration, lead at 6.4%
Xyleco, Inc. leads this historical grant record at 6.4% of D21B - foreign corporation assignees hold 55% of class grants (102 of 185). Figures describe granted US utility patents in this CPC subclass, not current investment or legal strength.
- Leader's share
- 6.4%
- Top three share
- 13.9%
- Lead over #2
- 9
29 of 452 grants
of the class's recorded grants
more grants than Valmet AB
Where D21B sits inside D21
Among 7 subclasses in D21 (PAPER-MAKING; Production OF Cellulose), D21B ranks #4 and holds 5.5% of the parent class's 8,169 recorded grants. Sibling chips below are the other subclasses in the same parent class, not the nationwide volume/lead-share peers further down.
Rising assignees active in D21B
Company-wide grant multiples (2022–2024 vs 2019–2021) among assignees with ≥5 patents in this subclass. Growth is company-wide; class patent counts are subclass-specific.
- #1 Valmet AB 1.96x 22 → 43 company-wide · 20 in D21B
- #2 Granbio Intellectual Property Holdings, LLC 1.53x 15 → 23 company-wide · 5 in D21B
- #3 Andritz Inc. 0.89x 37 → 33 company-wide · 7 in D21B
- #4 Fiberlean Technologies Limited 0.68x 19 → 13 company-wide · 14 in D21B
- #5 Upm-kymmene Corporation 0.67x 52 → 35 company-wide · 10 in D21B
D21B grants by year, peak 2021 (57)
US utility-patent grants per year in D21B, 2015–2025 - recent five years are up 11% versus 2015–2019.
Who leads D21B?
The 12 most active assignees in Fibrous RAW Materials OR Their Mechanical Treatment - wider bars mean more grants
- Xyleco
Xyleco, Inc.
29 patents
- Valmet Ab
Valmet AB
20 patents
- Fiberlean
Fiberlean Technologies Limited
14 patents
- Unicharm
Unicharm Corporation
13 patents
- Upm-kymmene 10
Upm-kymmene Corporation
10 patents
- Andritz 7
Andritz Inc.
7 patents
- Granbio Intellectual… 5
Granbio Intellectual Property Holdings, LLC
5 patents
- Forest Concepts 5
Forest Concepts, LLC
5 patents
- Virent 4
Virent, Inc.
4 patents
- Beta Renewables S p A 4
Beta Renewables S.p.A.
4 patents
- Westrock Mwv 3
WestRock MWV, LLC
3 patents
- The University of New… 3
The University of New Brunswick
3 patents
What this shows Seiko Epson is the most active filer in D21B, holding 111 of the 452 patents in this class. Concentration at the top signals how contestable this technology area is for new entrants.
View data table
| Rank | Company | Patents in D21B |
|---|---|---|
| #1 | Xyleco, Inc. | 29 |
| #2 | Valmet AB | 20 |
| #3 | Fiberlean Technologies Limited | 14 |
| #4 | Unicharm Corporation | 13 |
| #5 | Upm-kymmene Corporation | 10 |
| #6 | Andritz Inc. | 7 |
| #7 | Granbio Intellectual Property Holdings, LLC | 5 |
| #8 | Forest Concepts, LLC | 5 |
| #9 | Virent, Inc. | 4 |
| #10 | Beta Renewables S.p.A. | 4 |
| #11 | WestRock MWV, LLC | 3 |
| #12 | The University of New Brunswick | 3 |
| #13 | Qilu University of Technology | 3 |
| #14 | API Intellectual Property Holdings, LLC | 3 |
| #15 | Domtar Paper Company, LLC | 3 |
| #16 | Bouldin Corporation | 3 |
| #17 | Green Extraction Technologies | 3 |
| #18 | Zuiko Corporation | 2 |
| #19 | Andritz OY | 2 |
| #20 | Department of Biotechnology | 2 |
Footprint here vs. claim strategy
Each dot is a leading D21B assignee, placed by how many patents it holds in this class (horizontal) against its company-wide average claims per patent (vertical) - a read on whether the class is led by broad-but-shallow filers or focused deep-claim players.
Questions about D21B
Which company holds the most patents in D21B?
Which D21B assignees grew fastest recently?
How does D21B compare inside parent class D21?
What to do with this data
D21B in context - here's where to go next.
- Xyleco, Inc. leads D21B with 29 grants in this class. See full portfolio
- D21B ranks #550 of 670 by grant volume among all tracked CPC technology areas. See the ranking
- Inside parent class D21, the largest sibling subclass is D21H with 4,080 grants. Explore D21H
Figures reflect USPTO PatentsView grant data through 2026-05-15; pending applications not yet granted are not counted.
Methodology - D21B figures are USPTO PatentsView granted-utility totals for this subclass (452 grants in the tracked window).
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.